# Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD)

> **NCT01110811** · NA · COMPLETED · sponsor: **EndoGastric Solutions** · enrollment: 60 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease
- Hiatal Hernia

## Interventions

- **PROCEDURE:** Transoral Incisionless Fundoplication (TIF)

## Key facts

- **NCT ID:** NCT01110811
- **Lead sponsor:** EndoGastric Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2015-09
- **Final completion:** 2018-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110811, "Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01110811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*